Trial Profile
Randomized Phase III Trial Comparing Vinorelbine vs. Gemcitabine Plus Vinorelbine in Patients With Advanced Breast Cancer, Previously Treated With Anthracyclines and Taxanes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2021
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Vinorelbine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 05 Jun 2009 New trial record.